Kymera Therapeutics announced that patient enrollment has been completed for its mid-stage clinical trial targeting eczema.
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
Boosted by this news, the company’s stock price surged by 10.2% during pre-market trading. This development marks a key milestone in one of the company’s major R&D projects, paving the way for subsequent data analysis and clinical results evaluation. The market holds positive expectations for potential outcomes of this trial, which has driven the notable rise in the stock price.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
Spot Gold Falls Below $4000 per Ounce Again
BlockBeats•2026/06/26 02:39
Tether market cap surpasses Ethereum
AiCoin•2026/06/26 02:39
Bitcoin mining is on the brink of breakeven and undergoing structural adjustments
AiCoin•2026/06/26 02:34
Trending news
MoreCrypto prices
More
Bitcoin
BTC
$58,855.44
-3.23%
Tether USDt
USDT
$0.9985
+0.01%
Ethereum
ETH
$1,537.25
-4.94%
USDC
USDC
$0.9995
-0.02%
XRP
XRP
$1.02
-4.94%
Solana
SOL
$66.57
-1.75%
TRON
TRX
$0.3221
-1.53%
Hyperliquid
HYPE
$61.96
-2.48%
Dogecoin
DOGE
$0.07327
-3.82%
Zcash
ZEC
$405.52
-1.91%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now